PubMed

Myocardial protection in sepsis.

Shakar S, Lowes BD.

Crit Care. 2008;12(5):177. Epub 2008 Sep 3.PMID: 18828869 [PubMed - indexed for MEDLINE]Related articlesFree article

Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats.

Suzuki T, Morisaki H, Serita R, Yamamoto M, Kotake Y, Ishizaka A, Takeda J.

Crit Care Med. 2005 Oct;33(10):2294-301.PMID: 16215384 [PubMed - indexed for MEDLINE]Related articles

Beta-blockade during sepsis: inspired or insane?

Meldrum DR.

Crit Care Med. 2005 Oct;33(10):2433-4. No abstract available. PMID: 16215413 [PubMed - indexed for MEDLINE]Related articles

Sepsis-induced myocardial dysfunction and myocardial protection from ischemia/reperfusion injury.

McDonough KH, Virag JI.

Front Biosci. 2006 Jan 1;11:23-32. Review.PMID: 16146711 [PubMed - indexed for MEDLINE]Related articles

Mechanisms of sepsis-induced cardiac dysfunction.

Rudiger A, Singer M.

Crit Care Med. 2007 Jun;35(6):1599-608. Review.PMID: 17452940 [PubMed - indexed for MEDLINE]Related articles

Heart failure in pediatric septic shock: utilizing inotropic support.

Tabbutt S.

Crit Care Med. 2001 Oct;29(10 Suppl):S231-6. Review.PMID: 11593066 [PubMed - indexed for MEDLINE]Related articles

Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression.

Schmittinger CA, Dünser MW, Haller M, Ulmer H, Luckner G, Torgersen C, Jochberger S, Hasibeder WR.

Crit Care. 2008;12(4):R99. Epub 2008 Aug 4.PMID: 18680591 [PubMed - indexed for MEDLINE]Related articlesFree article

Molecular events in the cardiomyopathy of sepsis.

Flierl MA, Rittirsch D, Huber-Lang MS, Sarma JV, Ward PA.

Mol Med. 2008 May-Jun;14(5-6):327-36. Review.PMID: 18256728 [PubMed - indexed for MEDLINE]Related articlesFree article

Antioxidant vitamin therapy alters sepsis-related apoptotic myocardial activity and inflammatory responses.

Carlson D, Maass DL, White DJ, Tan J, Horton JW.

Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2779-89. Epub 2006 Jul 14.PMID: 16844910 [PubMed - indexed for MEDLINE]Related articlesFree article

Biologic rationale for the use of beta-blockers in the treatment of heart failure.

Sabbah HN.

Heart Fail Rev. 2004 Apr;9(2):91-7. Review.PMID: 15516856 [PubMed - indexed for MEDLINE]Related articles

Low-level inotropic stimulation with type III phosphodiesterase inhibitors in patients with advanced symptomatic chronic heart failure receiving beta-blocking agents.

Shakar SF, Bristow MR.

Curr Cardiol Rep. 2001 May;3(3):224-31. Review.PMID: 11305977 [PubMed - indexed for MEDLINE]Related articles

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine.

Crit Care Med. 2008 Jan;36(1):296-327. Erratum in: Crit Care Med. 2008 Apr;36(4):1394-6. PMID: 18158437 [PubMed - indexed for MEDLINE]Related articles

beta-Blockers in sepsis: reexamining the evidence.

Novotny NM, Lahm T, Markel TA, Crisostomo PR, Wang M, Wang Y, Ray R, Tan J, Al-Azzawi D, Meldrum DR.

Shock. 2009 Feb;31(2):113-9. Review.PMID: 18636043 [PubMed - indexed for MEDLINE]Related articles

Elucidating the role of reversible protein phosphorylation in sepsis-induced myocardial dysfunction.

Lorts A, Burroughs T, Shanley TP.

Shock. 2009 Jul;32(1):49-54. Review.PMID: 19533850 [PubMed - indexed for MEDLINE]Related articles

Myocardial structural changes in long-term human severe sepsis/septic shock may be responsible for cardiac dysfunction.

Rossi MA, Celes MR, Prado CM, Saggioro FP.

Shock. 2007 Jan;27(1):10-8.PMID: 17172974 [PubMed - indexed for MEDLINE]Related articles

Myocardial collagen changes and edema in rats with hyperdynamic sepsis.

Yu P, Boughner DR, Sibbald WJ, keys J, Dunmore J, Martin CM.

Crit Care Med. 1997 Apr;25(4):657-62.PMID: 9142032 [PubMed - indexed for MEDLINE]Related articles

The cellular and physiologic effects of beta blockers in heart failure.

Sabbah HN.

Clin Cardiol. 1999 Oct;22 Suppl 5:V16-20. Review.PMID: 10526699 [PubMed - indexed for MEDLINE]Related articles

[Heart damage associated with cerebrovascular accidents]

Illyés G, Herpai Z.

Orv Hetil. 1991 Apr 30;132(17):911-4, 917. Review. Hungarian. PMID: 1674128 [PubMed - indexed for MEDLINE]Related articles

Effects of isoproterenol on myocardial structure and function in septic rats.

Piper RD, Li FY, Myers ML, Sibbald WJ.

J Appl Physiol. 1999 Mar;86(3):993-1001.PMID: 10066715 [PubMed - indexed for MEDLINE]Related articlesFree article

[Perioperative pharmacological myocardial protection. Systematic literature-based process optimization]

Petzoldt M, Kähler J, Goetz AE, Friederich P.

Anaesthesist. 2008 Jul;57(7):655-69. Review. German. PMID: 18597062 [PubMed - indexed for MEDLINE]Related articles